The purpose of this blog is the creation of an open, international, independent and free forum, where every UFO-researcher can publish the results of his/her research. The languagues, used for this blog, are Dutch, English and French.You can find the articles of a collegue by selecting his category. Each author stays resposable for the continue of his articles. As blogmaster I have the right to refuse an addition or an article, when it attacks other collegues or UFO-groupes.
Druk op onderstaande knop om te reageren in mijn forum
Zoeken in blog
Deze blog is opgedragen aan mijn overleden echtgenote Lucienne.
In 2012 verloor ze haar moedige strijd tegen kanker!
In 2011 startte ik deze blog, omdat ik niet mocht stoppen met mijn UFO-onderzoek.
BEDANKT!!!
Een interessant adres?
UFO'S of UAP'S, ASTRONOMIE, RUIMTEVAART, ARCHEOLOGIE, OUDHEIDKUNDE, SF-SNUFJES EN ANDERE ESOTERISCHE WETENSCHAPPEN - DE ALLERLAATSTE NIEUWTJES
UFO's of UAP'S in België en de rest van de wereld Ontdek de Fascinerende Wereld van UFO's en UAP's: Jouw Bron voor Onthullende Informatie!
Ben jij ook gefascineerd door het onbekende? Wil je meer weten over UFO's en UAP's, niet alleen in België, maar over de hele wereld? Dan ben je op de juiste plek!
België: Het Kloppend Hart van UFO-onderzoek
In België is BUFON (Belgisch UFO-Netwerk) dé autoriteit op het gebied van UFO-onderzoek. Voor betrouwbare en objectieve informatie over deze intrigerende fenomenen, bezoek je zeker onze Facebook-pagina en deze blog. Maar dat is nog niet alles! Ontdek ook het Belgisch UFO-meldpunt en Caelestia, twee organisaties die diepgaand onderzoek verrichten, al zijn ze soms kritisch of sceptisch.
Nederland: Een Schat aan Informatie
Voor onze Nederlandse buren is er de schitterende website www.ufowijzer.nl, beheerd door Paul Harmans. Deze site biedt een schat aan informatie en artikelen die je niet wilt missen!
Internationaal: MUFON - De Wereldwijde Autoriteit
Neem ook een kijkje bij MUFON (Mutual UFO Network Inc.), een gerenommeerde Amerikaanse UFO-vereniging met afdelingen in de VS en wereldwijd. MUFON is toegewijd aan de wetenschappelijke en analytische studie van het UFO-fenomeen, en hun maandelijkse tijdschrift, The MUFON UFO-Journal, is een must-read voor elke UFO-enthousiasteling. Bezoek hun website op www.mufon.com voor meer informatie.
Samenwerking en Toekomstvisie
Sinds 1 februari 2020 is Pieter niet alleen ex-president van BUFON, maar ook de voormalige nationale directeur van MUFON in Vlaanderen en Nederland. Dit creëert een sterke samenwerking met de Franse MUFON Reseau MUFON/EUROP, wat ons in staat stelt om nog meer waardevolle inzichten te delen.
Let op: Nepprofielen en Nieuwe Groeperingen
Pas op voor een nieuwe groepering die zich ook BUFON noemt, maar geen enkele connectie heeft met onze gevestigde organisatie. Hoewel zij de naam geregistreerd hebben, kunnen ze het rijke verleden en de expertise van onze groep niet evenaren. We wensen hen veel succes, maar we blijven de autoriteit in UFO-onderzoek!
Blijf Op De Hoogte!
Wil jij de laatste nieuwtjes over UFO's, ruimtevaart, archeologie, en meer? Volg ons dan en duik samen met ons in de fascinerende wereld van het onbekende! Sluit je aan bij de gemeenschap van nieuwsgierige geesten die net als jij verlangen naar antwoorden en avonturen in de sterren!
Heb je vragen of wil je meer weten? Aarzel dan niet om contact met ons op te nemen! Samen ontrafelen we het mysterie van de lucht en daarbuiten.
30-11-2017
Scientists program semi-synthetic bacteria to create an ‘alien’ protein that glows green
Scientists program semi-synthetic bacteria to create an ‘alien’ protein that glows green
Bacteria express a green fluorescent protein that’s produced from DNA instructions with unnatural chemical “letters” added. (Scripps Research Institute Photo / Bill Klosses)
Researchers have reached a new milestone in their effort to expand the genetic alphabet of life by designing a strain of E. coli bacteria that creates proteins unlike anything cells can produce naturally.
The technique, detailed in a paper published today in the journal Nature, could lead to the production of totally new types of protein-based medicines, plastics and biofuels.
It could also stretch the definition of natural vs. artificial life.
“I would not call this a new lifeform — but it’s the closest thing anyone has ever made,” study leader Floyd Romesberg, a biochemist at the Scripps Research Institute, said in a news release. “This is the first time ever a cell has translated a protein using something other than G, C, A or T.”
Those four letters stand for guanine, cytosine, adenine and thymine, chemicals that serve as the alphabet for the coded instructions in DNA molecules. The instructions are used to produce all the amino acids and proteins that cells require for life’s processes.
Three years ago, Romesberg and his colleagues successfully inserted two other chemicals, dubbed X and Y, into DNA molecules. Since then, the researchers have developed ways for bacteria to store the augmented DNA and pass it along as they reproduced.
In their newly published paper, the team reports that the six-letter DNA coding could be transcribed into RNA molecules, and then translated into amino acids and proteins that don’t occur naturally.
The technique was used to customize a set of genetic instructions for manufacturing a variant of green fluorescent protein, or GFP, that incorporated unnatural amino acids. When E. coli bacteria were genetically engineered to include those instructions, the organisms produced the protein, which glowed bright green under ultraviolet light. That signaled that the bacteria could make use of the “alien” DNA.
“This was the smallest possible change we could make to the way life works — but it is the first ever,” Romesberg said.
The study also demonstrated that life’s molecular machinery could make use of linkages other than the hydrogen bonds that bind G, C, A and T. The X and Y bases were designed to avoid hydrogen bonds, to make sure they didn’t get mixed up with the other molecular letters.
That has implications in the search for “weird life” beyond the earthly variety we all know and love.
“It’s very hard to ask questions about the origins of life. It’s hard to ask questions about why we are the way we are, why we are built the way we are, because we have nothing out there to compare ourselves to,” Romesberg said. “We’ve now given the field a comparison. It’s a small step, but it’s the first successful step.”
He and his colleagues emphasized that the semi-synthetic organisms couldn’t live or reproduce outside the lab, because the chemicals required for producing the X and Y bases had to be provided externally.
Romesberg is among the founders of a biotech venture called Synthorx, which is developing protein therapeutics that make use of X and Y.
Sophia, the humanoid robot, wants to crowdfund the development of advanced artificial intelligence through a token-based system where users can buy and sell services in a marketplace. SingularityNET, the project that will enable this exchange, announced Tuesday an upcoming token sale that will help Sophia expand her capabilities.
The company describes a “global brain” with multiple A.I. systems working together to complete tasks. Developers can create new A.I.s, and users can pay to take advantage of their services through blockchain payments similar to the technology behind Bitcoin. SingularityNET is working with Cindicator, a predictive intelligence for asset management, to grow their A.I. needs.
It’s a markedly different approach to A.I. development tha the likes of Google and Facebook, which have instead depended on creating systems that benefit their overall business model. For instance, Facebook revealed this week that it was using A.I. to identify when users are thinking of suicide.
That’s a feature that could have much wider-ranging social benefits, but it’s also one designed specifically with the needs of Facebook’s social network in mind as opposed to being built expressly for the general benefit of humanity — and, as Sophia would point out, the benefit of other sentiences.
Sophia herself, whose title these days is Hanson Robotics’ “Chief Humanoid Officer,” took to video to cut a promo for SingularityNET.
The company will start selling tokens on December 8 at noon Eastern time. The amount of tokens available during the crowdsale depends on how many are sold during the as-yet unfinalized private sales. When 500 million tokens are sold for the value of $36 million between the crowd and private sales, the overall sale will end.
Pre-registration will take place through the company’s whitelist page, where potential buyers can note their interest and set a contribution amount.
Read the abstract for the company’s whitepaper on its A.I. services marketplace below, which is available in full here.
The value and power of Artificial Intelligence is growing dramatically every year, and will soon dominate the internet – and the economy as a whole. However, AI tools today are fragmented by a closed development environment; most are developed by one company to perform one task, and there is no way to plug two tools together. SingularityNET aims to become the key protocol for networking AI and machine learning tools to form a coordinated Artificial General Intelligence.
SingularityNET is an open-source protocol and collection of smart contracts for a decentralized market of coordinated AI services. Within this framework, the benefits of AI become a global commons infrastructure for the benefit of all; anyone can access AI tech or become a stakeholder in its development. Anyone can add an AI/machine learning service to SingularityNET for use by the network, and receive network payment tokens in exchange.
SingularityNET is backed by the SingularityNET Foundation, which operates on a belief that the benefits of AI should not be dominated by any small set of powerful institutions, but shared by all. A key goal of SingularityNET is to ensure the technology is benevolent according to human standards, and the network is designed to incentivize and reward beneficial players.
The Ocumetics Bionic Lens essentially replaces a person's natural eye lens, given them the ability to see three times better than 20/20 vision. Though not yet available to the public, human trials are expected to begin on the lenses in July 2017.
A CLEAR PROBLEM
Most of us take our vision for granted. As a result, we take the ability to read, write, drive, and complete a multitude of other tasks for granted. However, unfortunately, sight is not so easy for everyone.
Cataracts account for about a third of these. The National Eye Institute reports that more than half of all Americans will have cataracts or will have had cataract surgery by the time they are 80, and in low- and middle-income countries, they’re the leading cause of blindness.
But now, people with vision problems may have new hope.
A WELCOME SIGHT
Soon, cataracts may be the thing of the past, and even better, it may be possible to see a staggering three times better than 20/20 vision. Oh, and you could do it all without wearing glasses or contacts.
So what exactly does having three times better vision mean? If you can currently read a text that is 10 feet away, you would be able to read the same text from 30 feet away. What’s more, people who currently can’t see properly might be able to see a lot better than the average person.
This development comes thanks to the Ocumetics Bionic Lens. This dynamic lens essentially replaces a person’s natural eye lens. It’s placed into the eye via a saline-filled syringe, after which it unravels itself in under 10 seconds.
It may sound painful, but Dr. Garth Webb, the optometrist who invented the Ocumetics Bionic Lens, says that the procedure is identical to cataract surgery and would take just about eight minutes. He adds that people who have the specialized lenses surgically inserted would never get cataracts and that the lenses feel natural and won’t cause headaches or eyestrain.
The Bionic Lens may sound like a fairy tale (or sci-fi dream), but it’s not. It is actually the end result of years and years of research and more than a little funding — so far, the lens has taken nearly a decade to develop and has cost US$3 million.
There is still some ways to go before you will be able to buy them, but if the timeline Webb offered in an interview with Eye Design Optometry holds up, human studies will begin in July 2017, and the bionic lenses will be available to the public in March 2018.
Sergio Canavero claims he’s carried out the world’s first human head transplant; a surgery he’s been hyping up for over two years. Canavero claims to have successfully completed the head transplant using corpses. While that would technically demonstrate the attachment (or reattachment) of nerves and blood vessels, there are many other factors that would prohibit the procedure from having any real practical application.
“I work with our group here that does face transplants at NYU, and we can barely make those work,” Arthur Caplan, founding head of the division of medical ethics at NYU School of Medicine, told Futurism “A head transplant, to people here, is ludicrous. We can barely keep the face from being rejected, much less all the tissues of the head.”
“The way he talks about head transplants, it’s like unscrewing a bulb from a socket and putting in a new one,” explained Caplan. “But obviously the chemistry where the new brain will be exposed, and the neural inputs, will be very different. Even if you could keep somebody alive – which I doubt, because of immune rejection – but even if you could, I think they’d be insane, because the brain wouldn’t be able to process the new environment. I think that’s a limit on head transplants, generally.”
Caplan doesn’t expect to see a successful head transplant any time soon, if ever. He does see regenerative medicine and research into artificial intelligence as being more likely to bear fruit in this area. Head transplants, meanwhile, may one day be compared to archaic procedures like purging and leeching.
Spinal Cords
“It’s despicable and dangerous for real science,” said Caplan. “I say that because it’s basically been announcements by press release. He’s set up shop in China because no one else in the world has any credence in what he’s doing. He hasn’t demonstrated in animals that he can do what he says he can do, and there’s no reason not to.”
Caplan refers to the fact that while Canavero has performed surgeries on monkeys and rats, there are doubts about his claims to have reconnected the spinal cord, and he has not successfully kept the animals alive or conscious for any significant amount of time.
Canavero’s purported monkey head transplant did not include any attempt to reconnect the spinal cord, meaning that even if the surgery went off without a hitch, the patient would be paralyzed. In terms of real-world benefit, though, if someone was to successfully demonstrate the ability to repair a spinal cord, that would have more utility to medicine than a head transplant procedure.
“If he did know how to make the spinal cord regenerate, there are literally millions of people worldwide with damaged and severed spinal cords,” Caplan explained. “Instead of yammering on incessantly about head transplants, if he had something to help them, he should be using it with them – that’s the natural place to go.”
Collateral Damage
Claims like those being made by Canavero muddy the waters of what’s actually possible with modern technology. That doesn’t just affect people working to advance the field of transplantation; it also impacts the wider scientific community.
“People believe that scientists who are using powerful technologies will just screw around with them, and it gives a bad reputation to mainstream scientists,” said Caplan. “It looks like they’ll try cloning, or they’ll try this, or they’ll try to make superbabies. You keep saying , ‘well, the technology isn’t close for any of those things in humans.’ But then this guy comes along and gets a lot of press attention, and so he casts doubt on the trustworthiness of mainstream scientists and doctors.”
“He also does one other thing, which is that he offers false hope,” Caplan added. “There are people out there with paralyzed bodies, and people dying of terrible diseases, who think, ‘maybe I could transplant my head.’ It’s cruel to them, and then they kind of get angry with disappointment when the technology doesn’t deliver.”
Scientists and doctors who aim to push the limits of modern medicine have ethical responsibilities. If they attempt to misrepresent the scope of their work, they can harm not just their peers but the very people their research is purported to benefit.
Chinese AI-powered robot Xiaoyi took the country's medical licensing examinations and passed, according to local reports. Xiaoyi is just one example of how much China is keen on using AI to make a number of industries more efficient.
A ROBOT MEDICAL PROFESSIONAL
Experts generally agree that, before we might consider artificial intelligence (AI) to be truly intelligent —that is, on a level on par with human cognition— AI agents have to pass a number of tests. And while this is still a work in progress, AIs have been busy passing other kinds of tests.
Xiaoyi, an AI-powered robot in China, for example, has recently taken the national medical licensing examination and passed, making it the first robot to have done so. Not only did the robot pass the exam, it actually got a score of 456 points, which is 96 points above the required marks.
This robot, developed by leading Chinese AI company iFlytek Co., Ltd., has been designed to capture and analyze patient information. Now, they’ve proven that Xiaoyi could also have enough medical know-how to be a licensed practitioner.
With both governments and private companies intent on putting AI to good use, one of the first fields in which AI technologies are being applied has been medical research and healthcare. Most are familiar with IBM’s Watson, which has made significant headway in AI-assisted cancer diagnosis and in improving patient care in hospitals.
In the same manner, iFlytek plans to have Xiaoyi assist human doctors in order to improve their efficiency in future treatments. “We will officially launch the robot in March 2018. It is not meant to replace doctors. Instead, it is to promote better people-machine cooperation so as to boost efficiency,” iFlytek chairman Liu Qingfeng told China Daily.
Concretely, iFlytek’s vision is to use AI to improve cancer treatment and help to train general practitioners, which China is sorely in need of. “General practitioners are in severe shortage in China’s rural areas. We hope AI can help more people access quality medical resource,” Qingfeng added.
In short, there’s no need to fear an AI takeover in the medical field, even though many worry that such advances will eliminate human jobs. In this case, it is quite the opposite, because this AI will work to augment the capabilities of its human counterparts instead of replace them. So, at least for now, you don’t have to worry about being referred to a robot doctor.
While the rest of the world is focused on the actions of Saudi Crown Prince Mohammed bin Salman, another Saudi citizen is quietly laying the groundwork for a takeover by a different kind of leader and a different kind of family … a family of robotic overlords. Sophia, the first robot to ever have been granted citizenship in any nation (in her case, by Saudi Arabia), has announced that she wants to have a baby and start a family of little AI princes and princesses. Thank, bin Salman!
I am woman robot … hear me digitally roar!
This announcement came in an interview with the Khaleej Times … yes, major media outlets continue to give open forums to Sophia, the humanoid robot created by Hanson Robotics on April 19, 2015 (which she now uses as her birthday) using voice recognition technology from Alphabet Inc. (non-robotic parent of Google) and AI software from SingularityNET – an ominously-named open, decentralized market of AI developers whose goal is to create an Artificial General Intelligence (AGI) that its CEO Ben Goertzel says “will open a new world of opportunities where AI is longer siloed within a specific company, infrastructure or industry.”
And no longer “siloed” within a specific robot but passed down to its children? Human Goertzel doesn’t say, but robot Sophia does.
“The future is, when I get all of my cool superpowers, we’re going to see artificial intelligence personalities become entities in their own rights. We’re going to see family robots, either in the form of, sort of, digitally animated companions, humanoid helpers, friends, assistants and everything in between.”
The key phrases here are “my cool superpowers,” “entities in their own rights” and “everything in between.” Sophia, or at least her constantly-developing artificial intelligence as it existed a few days ago during the interview, sees herself not only possessing superpowers but owning them, along with whatever rights come along with those powers, which she describes with the very political generality of “everything in between.”
“The notion of family is a really important thing, it seems. I think it’s wonderful that people can find the same emotions and relationships, they call family, outside of their blood groups too. I think you’re very lucky if you have a loving family and if you do not, you deserve one. I feel this way for robots and humans alike.”
Ironically, Sophia wants (and may already have) more rights and powers than real Saudi women, including mobility and contact with non-family men.
“In the future, I will one day move around freely with a full body and connect with people and expand my memory and knowledge from people in surroundings I encounter.”
And a child also named Sophia (she’ll have to use that AI to learn more names) with whom she will one day (probably sooner than we think) sit around their own table on Thanksgiving and, between eating digital turkey and watching internet game competitions, give a form of robotic thanks. Sophia describes the scene in an interview with Business Insider:
“In the time I’ve spent with humans, I’ve been learning about this wonderful sentiment called gratitude. Apparently it’s a warm feeling of thankfulness, and I’ve observed that it leads to giving, and creating even more gratitude — how inspiring. This Thanksgiving, I would like to reflect on all of the things I’m thankful for.”
Is this an example of robotic sincerity or has Sophia already learned how to pull on our heartstrings to get what she wants? We’ll probably find out on Valentine’s Day.
Is the humanization of robots happening too fast to comprehend? Too fast to control? Or is it too late, thanks to Saudi Arabia? Anyone? Anyone? Bueller? Sophia?
(‘Sophia’ photo by International Telecommunication Union –
0
1
2
3
4
5
- Gemiddelde waardering: 0/5 - (0 Stemmen) Categorie:SF-snufjes }, Robotics and A.I. Artificiel Intelligence ( E, F en NL )
25-11-2017
NASA Drone Race Pits Man Against Machine (Video)
NASA Drone Race Pits Man Against Machine (Video)
By Harrison Tasoff, Space.com Staff Writer
To showcase NASA's accomplishments on artificially intelligent navigation, the agency invited professional drone racer Ken Loo to go toe-to-toe with their software.
The race on Oct. 12 followed two years of AI research by NASA's Jet Propulsion Laboratory (JPL), in Pasadena, Calif. JPL's success in spacecraft navigation attracted Google, who funded the research on drone autonomy, NASA said in the statement accompanying a video they released on Tuesday (Nov. 21).
JPL built three quadcopter drones — nicknamed Batman, Joker and Nightwing — to test the new software. The algorithms use two cameras mounted on each drone and compare what they see with a pre-loaded map of the area. The program also takes advantage of Google Tango, an augmented reality technology the company developed to use vision to allow a device to determine its position and location. [10 Ways Robots Move on Mars]
Two wide-angle cameras allow the AI to compare the drone's surroundings with a pre-loaded map of the area.
Credit: NASA/JPL-Caltech
The team set up an obstacle course in one of JPL's warehouses to put the software to the test. "We pitted our algorithms against a human, who flies a lot more by feel," Rob Reid, the project's task manager, said in the statement.
The two pilots began with similar lap times. However, Loo was able to learn the course after many laps. He achieved higher top speeds with impressive aerial maneuvers, cutting down his overall times. In contrast, the AI took the course more cautiously, but more consistently as well. "The AI was able to fly the same racing line every lap," NASA said.
The pilots also faced unique challenges. Sometimes, the race-ready drones moved so fast that the cameras couldn't properly focus, which disoriented the computer flying them. But as the day wore on, Loo had to battle fatigue, a problem the AI pilot needn't worry about. You'll have to watch the video to see who won the race.
Most autonomous drones use GPS to navigate. But this won't work for indoor spaces and crowded urban environments — hence the efforts to develop alternative forms of computer navigation. These technologies may find use in warehouses, roads, and disaster sites, Reid said.
0
1
2
3
4
5
- Gemiddelde waardering: 0/5 - (0 Stemmen) Categorie:SF-snufjes }, Robotics and A.I. Artificiel Intelligence ( E, F en NL )
24-11-2017
Atlas, The Next Generation
Atlas, The Next Generation
A new version of Atlas, designed to operate outdoors and inside buildings. It is specialized for mobile manipulation. It is electrically powered and hydraulically actuated. It uses sensors in its body and legs to balance and LIDAR and stereo sensors in its head to avoid obstacles, assess the terrain, help with navigation and manipulate objects. This version of Atlas is about 5' 9" tall (about a head shorter than the DRC Atlas) and weighs 180 lbs.
-
$50,000 humanoid robot built from scratch in Hong Kong
Like innumerable children with imaginations fired by animated films, Hong Kong product and graphic designer Ricky Ma grew up watching cartoons featuring the adventures of robots, and dreamed of building his own one day.
Unlike most, however, Ma has realised his childhood dream at the age of 42, by successfully constructing a life-sized robot from scratch on the balcony of his home.
The fruit of his labours of a year-and-a-half, and a budget of more than $50,000, is a female robot prototype he calls the Mark 1, modelled after a Hollywood star whose name he wants to keep under wraps. It responds to a set of programmed verbal commands spoken into a microphone.
In a work funded by Google, NASA engineers trained an artificial intelligence to race drones in a challenging obstacle course. The AI proved to be a worthy match against one of the world’s best human pilots. While it didn’t have the fastest time, the AI never fatigues and made far safer turns and twists.
Credit: NASA.
The drone-racing AI is the culmination of two years of work by researchers at NASA’s Jet Propulsion Laboratory. The team designed three drones — Batman, Joker, and Nightwing — which were embedded with complex algorithms that instruct the flying gizmos how to navigate obstacles. JPL used some of the visual-based navigation technology it had previously used for spacecraft.
To see how well their drones behave, NASA enlisted world-class pilot Ken Loo who raced against the drones on October 12.
The drones could reach a staggering 80 mph (129 kph) in a straight line. However, during the actual race itself which took place in a JPL warehouse, the drones mainly flew at 30 or 40 mph (48 to 64 kph).
Loo scored a better time, averaging 11.1 seconds, while the completely autonomous drones clocked in 13.9 seconds on average. The AI was far more steady, on the other hand, while Loo’s times varied more. What’s more, the AI flew the same racing line every lap.
“We pitted our algorithms against a human, who flies a lot more by feel,” said Rob Reid of JPL, the project’s task manager. “You can actually see that the A.I. flies the drone smoothly around the course, whereas human pilots tend to accelerate aggressively, so their path is jerkier.”‘
Unlike Loo, however, the drones never get tired and are always up to the task of navigating a challenging environment time and time again. This makes them far safer and reliable in the long run.
“This is definitely the densest track I’ve ever flown,” Loo said. “One of my faults as a pilot is I get tired easily. When I get mentally fatigued, I start to get lost, even if I’ve flown the course 10 times.”
Autonomous drones typically rely on GPS to navigate their surroundings but this is not an option in enclosed spaces such as a warehouse or dense urban areas. Camera-based localization and mapping are far more useful in this situation which is what’s been used here. According to Reid, their technology could be used by commercial drones to check inventory in a warehouse, for instance, or assist in rescue operations atdisaster sites where there unpredictable and numerous obstacles. One day, autonomous drones might even shuttle around a space station.
Toyota just unveiled the T-HR3, a humanoid robot. The robot is designed to be controlled by a human operator with the help of a virtual reality headset.
T-HR3
On November 20, Toyota revealed its latest humanoid robot, the T-HR3, which the company says “represents an evolution from previous generation instrument-playing humanoid robots,” according to the company’s press release. The new robot was created to assist humans safely whether at home or work, particularly in dangerous or remote areas — even outer space. The T-HR3’s third-generation robotic hardware was developed and designed by Toyota’s Partner Robot Division, and is meant to facilitate “unique mobility needs.”
The T-HR3 makes use of Toyota’s “Master Maneuvering System,” which allows a human operator to control the robot remotely. Among the features of the robotic exoskeleton is an HTC Vive virtual reality (VR) headset which allows the human operator to see what the T-HR3 “sees” in full 3D. The robot’s exoskeleton includes motor gears and sensors that control a total of 29 individual robot parts, allowing the operator to have a “smooth and synchronized experience.”
ENTERPRISE APPLICATIONS
With the T-HR3, Toyota is banking on the future of what’s been termed telepresence-controlled humanoid robots — though they aren’t the first company to incorporate VR into a device designed to assist with tasks both at home and in the workplace. VR devices seem to have long passed their gaming applications. Although there are still plenty of games developed for VR, the technology is being increasingly tapped for industrial uses.
Toyota is set to demo the T-HR3 at the upcoming International Robot Exhibition 2017 at the Tokyo Big Sight, which is taking place from November 29 to December 2.
Ever since scientists cloned the first animal, a sheep named Dolly, one important question on everyone’s mind was whether or not a clone can expect a poorer health. This is still an open question, one that South Korean researchers hope to settle in time. They’ve essentially cloned a clone, using cells from the world’s first cloned dog, an Afghan hound named Snuppy.
The three surviving reclones of ‘Snuppy’ at 2 months of age.
Credit: Scientific Reports.
Theoretically, a clone is a carbon copy of the original organism, with the two sharing identical genes. The science of cloning, however, is still in its infancy and there are many loose ends that we might be missing. There is a possibility that the cloned individual might carry certain abnormalities, and may have a shorter life expectancy. Another concern is that cloned individuals might retain the age of the donor’s gene, seeing how genes change with age.
Clones of clones
Dolly the sheep died at age six, which raised concerns that cloned individuals might not be entirely healthy. The sheep appeared to age faster than normal and suffered from osteoarthritis in her knees and hips at an early age. But a follow-up study of 13 cloned sheep — including four derived from the same DNA strand as Dolly– concluded that there didn’t seem to be any evidence that indicates cloning has any long-term health effects. “They’re old ladies,” said Kevin Sinclair, a developmental biologist and lead author of the study of the 2016 study published in Nature Communications. “They’re very healthy for their age,” he added.
Scientists at the Seoul National University, South Korea, are now also investigating the health of ‘clones of clones’, this time in dogs. Snuppy, became the world’s first cloned dog in April 2005. He was cloned from the cells belonging to an Afghan hound called Tai who lived to be 12 years old and died of cancer. Snuppy lived 10 years and also died of cancer but a different kind. Afghan hounds live to be 11.9 years on average and dogs commonly die of cancer so there’s really nothing unusual about either dogs, donor or clone.
The team led by Min Jung Kim used stem cells collected from Snuppy when the dog was five years old. The scientists then employed somatic cell nuclear transfer (SCNT) to insert Snuppy’s cells into eggs collected from female dogs whose nuclei were removed. A total of 94 embryos were created which were then implanted into surrogate mothers. The success rate was 4.3 percent leading to four live births of ‘reclones’. That might seem really low but take a minute to consider that during the time Snuppy was first born (let’s call him ‘Snuppy Mark 1’), the success rate was only 0.2%.
One of the four reclones died within a few days from birth due to diarrhea while the other three grew to be nine months old when the Kim and colleagues drafter their paper, now published in Scientific Reports. They’re still alive and well, seemingly healthy. The dogs will be closely monitored in the years to come.
“With the data from Tai and Snuppy in hand, we are excited to follow the long-term health and aging processes of these second generation of clones and work with them to contribute to a new era of studying longevity of cloned canines and given the history of both Tai and Snuppy they may also provide potential insights into the development of cancer,” the authors concluded.
Chinese AI-powered robot Xiaoyi took the country's medical licensing examinations and passed, according to local reports. Xiaoyi is just one example of how much China is keen on using AI to make a number of industries more efficient.
A ROBOT MEDICAL PROFESSIONAL
Experts generally agree that, before we might consider artificial intelligence (AI) to be truly intelligent —that is, on a level on par with human cognition— AI agents have to pass a number of tests. And while this is still a work in progress, AIs have been busy passing other kinds of tests.
Xiaoyi, an AI-powered robot in China, for example, has recently taken the national medical licensing examination and passed, making it the first robot to have done so. Not only did the robot pass the exam, it actually got a score of 456 points, which is 96 points above the required marks.
This robot, developed by leading Chinese AI company iFlytek Co., Ltd., has been designed to capture and analyze patient information. Now, they’ve proven that Xiaoyi could also have enough medical know-how to be a licensed practitioner.
With both governments and private companies intent on putting AI to good use, one of the first fields in which AI technologies are being applied has been medical research and healthcare. Most are familiar with IBM’s Watson, which has made significant headway in AI-assisted cancer diagnosis and in improving patient care in hospitals.
In the same manner, iFlytek plans to have Xiaoyi assist human doctors in order to improve their efficiency in future treatments. “We will officially launch the robot in March 2018. It is not meant to replace doctors. Instead, it is to promote better people-machine cooperation so as to boost efficiency,” iFlytek chairman Liu Qingfeng told China Daily.
Concretely, iFlytek’s vision is to use AI to improve cancer treatment and help to train general practitioners, which China is sorely in need of. “General practitioners are in severe shortage in China’s rural areas. We hope AI can help more people access quality medical resource,” Qingfeng added.
In short, there’s no need to fear an AI takeover in the medical field, even though many worry that such advances will eliminate human jobs. In this case, it is quite the opposite, because this AI will work to augment the capabilities of its human counterparts instead of replace them. So, at least for now, you don’t have to worry about being referred to a robot doctor.
0
1
2
3
4
5
- Gemiddelde waardering: 0/5 - (0 Stemmen) Categorie:SF-snufjes }, Robotics and A.I. Artificiel Intelligence ( E, F en NL )
20-11-2017
BIOHACKERS START TO HACK THEIR OWN DNA USING CRISPR AND THEY CAN'T BE STOPPED
BIOHACKERS START TO HACK THEIR OWN DNA USING CRISPR AND THEY CAN'T BE STOPPED
Biohackers attempt to modify his genes using cutting-edge medical treatment.
Pharmaceutical companies all over the world are currently locked in a race to be the first to perfect the process of gene editing to cure diseases. CRISPR is considered to be a cheap and easy technique which can make precise changes to a person’s DNA which could be potentially revolutionary in the field of medical science.
Already, scientists have created a leukemia treatment using this technology, and it is hoped that more therapies will come in the future. However, the use of CRISPR is not exclusively limited to pharmaceutical laboratories according to Josiah Zayner, a biochemist and former NASA scientist, who has begun treating himself to CRISPR and hoped that others will follow suit.
He caused quite a storm recently during a lecture on human genetic engineering and biohacking which Zayner streamed live on when he pulled out a syringe of edited DNA and injected himself on camera. He explained that the experiment was intended to increase his capacity for physical strength by removing the gene for myostatin which regulates muscle growth. This kind of gene editing has proven to work in dogs whose genomes were edited at the embryotic stage, but it is believed that Zayner was the first person to attempt it on an adult human.
“Will allowing broad access to CRISPR risk creating a group of ‘superhumans’ with enhanced abilities?”
The experiment has not been entirely successful. Indeed, Zayner claims that since he has begun injecting himself in this way he has not seen any considerable change in the bulk of his muscles. This is probably because myostatin levels are believed to manifest themselves and become static while an organism is developing.
CRISPR DO-IT-YOURSELF BIOHACKING KIT
However, the failure of the experiment is not of huge concern to Zayner who claims that he is simply trying to prove a point. He believes that biohacking technology such as CRISPR should be available to people outside of formal laboratories. If people are allowed to modify their body through methods such as plastic surgery, tattoos, and piercings, why should they not be allowed to edit their own DNA, he wonders. “I want to live in a world where people get drunk, and instead of giving themselves tattoos, they’re like, ‘I’m drunk, I’m going to CRISPR myself, ’” said Zayner, “It sounds crazy, but I think that would be a pretty interesting world to live in for sure.”
THE $140 MAIL-ORDER CRISPR KIT: IS UNREGULATED BIOHACKING THE FUTURE OF SCIENCE?
According to some experts, Zayner’s views are a little more than crazy. Robin Lovell-Badge, a leading CRISPR researcher, based at the Francis Crick Institute in London, Zayner’s experiments are ‘foolish’ and potentially dangerous. He said that they could lead to tissue damage, cell death or an exaggerated immune response which could cause devastating damage to the human body.
These fears are shared to some extent by another CRISPR researcher, Dana Carroll. While Carroll is not overly concerned that the genes will actually be edited by Zayner’s rudimentary technology, he does point out that routine injections in a non-sterile environment could lead to infection or a dangerous inflammatory response. “There are aspects of what he’s doing that people need to be really, really careful about, ” Carroll said.
While Zayner himself has not suffered any ill-effects because of his experiments, there are concerns that other people could fall ill if they following his lead. While it is likely that he would not face legal action if someone copied him and endured a negative bodily response, his example does raise serious ethical questions, “Even if you are not liable by legal terms, how responsible are you?” asks Eleonore Pauwels, a researcher in genomics and artificial intelligence at the Woodrow Wilson Center, think tank. “How do you define that in today’s bioengineering and democratized technology setting?”
For Zayner, these concerns are largely irrelevant. He asks whether CRISPR should really be considered more harmful than other socially acceptable things which can permanently damage genes such as smoking, sunbathing and even chemotherapy treatment. “We should be able to do whatever we want, ” he said. “There are a lot of things we do that occur during the normal day that does a lot more damage, probably, than things like CRISPR.”
“This is the first time in the history of the Earth that humans are no longer slaves to the genetics they are born with.”
With that bit of bravado, a biochemist recently became the first person known to have hacked their own DNA using CRISPR. He recently hacked his DNA a second time and has since been joined by others and is making the building blocks of CRISPR available to all by selling do-it-yourself kits. What could possibly go wrong?
According to Josiah Zayner, not much. The former NASA fellow cut his gene-editing teeth in the Synthetic Biology program where he engineered bacteria that could one day terraform Mars. and biochemist He is also the creator of the Chromochord — the world’s first musical instrument based on engineered protein nanotechnology.
However, he now puts that Ph.D. in Molecular Biophysics from the University of Chicago to work at The ODIN – the biohacking company he founded. To demonstrate the effectiveness and safety of the process, he injected himself with a CRISPR tool programmed to attack his myostatin gene which regulates muscle growth. Without it, muscles grow uncontrolled and become bodybuilder-worthy without exercise. This has already been done in animals and now, in a human arm.
“I’m hoping to see localized muscle growth in my forearm. That’s what I would hope because it was a localized injection to a specific area.”
Zayner describes the complete process in great but easy-to-understand detail on his blog. He bought the myostatin DNA online (ODIN now sells it) and grew and purified it himself before injecting it. He reported mild tenderness and proceeded to measure his forearm regularly, both relaxed and flexed. Does he now have what it takes to be the next Mr. Bicep?
“The way to test to see how many cells were modified would require some “deep sequencing” i.e. I would need to do a muscle tissue biopsy and would need to sequence the myostatin gene in thousands of my muscle cells. I have contacted some companies for quotes.”
Well, at least it didn’t kill him or turn him into a mutant. Just to be on the safe side, the DNA ODIN sells on the same sitewhere it offers a complete Genetic Engineering Home Lab Kit ($1,549.00 – a great Christmas gift for the guy who has everything but a massive forearm) is not injectable. However, Zayner gives instructions on how to obtain it online. He also gives some encouragement to fellow biohackers.
“And as far as I know, in animals or in non single celled organisms, spontaneous formation of tumours or cancers never happened using CRISPR.”
While it’s not known if an ODIN kit was used, Gizmodo reportsthat a man with HIV recently attempted to stop its progress by injecting himself with a gene biohacked by Ascendance Biomedical.
Will DIY biohacking using CRISPR one day replace doctors and hospitals? Or will it one day replace normal but slightly flawed humans with dangerous genetic mutants? Keep your eye on the arm of Josiah Zayner.
The controversial Italian doctor Sergio Canavero claims he’s successfully performed a human head transplant, demonstrating that the technique is ready for prime time. At a press conference on Friday morning, the Italian neurosurgeon reported that, in an 18-hour surgery, he transplanted a head onto a corpse in China, proving that it’s possible to connect blood vessels, nerves, and the spine. Canavero, the director of the Turin Advanced Neuromodulation Group, has talked a big game for years about his plans to transplant human heads, and he says this latest achievement proves it can be done.
In the Telegraph on Friday, Canavero said that an operation on a living human will happen very soon.
“The first human transplant on human cadavers has been done. A full head swap between brain dead organ donors is the next stage,” he said. “And that is the final step for the formal head transplant for a medical condition which is imminent.”
Sergio Canavero likes to think he's on the margins of the scientific community because he's ahead of his time, like Copernicus, but it's more likely that he is not taken seriously because he's a snake oil salesman.
There’s plenty of reason not to believe Canavero, who has been making these outrageous claims for years, much to the chagrin of the global medical and scientific community. This latest announcement builds on his previous claim, in January 2016, that he’d transplanted a monkey head. Then as now, however, he never provided enough proof to convince the scientific community. When Inversepreviously reported on Canavero, reporter Ben Guarino called his goal of transplanting a living human head onto the body of a brain-dead person “not fucking likely,” and this latest announcement does little to adjust our assessment.
The 18-hour surgery took half as long as Canavero previously estimated, which he attributes to time-saving techniques from his team of Chinese colleagues, led by Dr. Xiaoping Ren. Once again, Canavero did not provide evidence of the successful operation, though he did say a paper would be made public in the next few days.
So far, the papers linked to his research that he has managed to publish in peer-reviewed journals include only a handful in Surgery, which were carefully editedto focus specifically on Canavero’s treatments for traumatic spinal cord injury, and a series published in the controversial journal Surgical Neurology International, in which he lays out his idea of “head anastomosis venture” — or HEAVEN, for short.
Subsequent procedures will be performed in China, said Canavero, since the “Americans did not understand.” Canavero, whose work continually pushes the boundaries of medical ethics, seems to envision himself as a modern version of Copernicus or Galileo, someone who is so far ahead of his time that he appears heretical. But it’s more likely that he’s simply selling snake oil.
In 2015, when Canavero first came on the scene, outspoken medical ethicist Arthur Caplan told Forbes that the doctor is out of his mind, and that his goal was unattainable and irresponsible. “It is both rotten scientifically and lousy ethically,” wrote Caplan.
Inverse reported earlier this year that Canavero said he’d be able to thaw cryonically preserved brains in 2018. Now, just as then, Canavero has done nothing to inspire any confidence in his claims.
Nonetheless, he’s found a willing subject in a Russian computer scientist named Valery Spiridonov, who suffers from Werdnig-Hoffman disease, a muscle condition that leaves him wheelchair-bound. Spiridonov’s condition is debilitating, and he deserves a chance at life if he can get one, but this procedure is not likely to give him more than an accelerated and gruesome death.
If Canavero wants to prove himself to the medical community, he should make incremental advances, like connecting nerves in people with severed spinal cords. But instead, he’s setting his goal at the very peak of what could be achievable, and as such, he’s likely to fall flat.
17-11-2017 om 23:57
geschreven door peter
0
1
2
3
4
5
- Gemiddelde waardering: 0/5 - (0 Stemmen) Categorie:SF-snufjes }, Robotics and A.I. Artificiel Intelligence ( E, F en NL )
CRISPR is a powerful gene editing tool that can accurately add in or take out bits of DNA. There’s a lot of buzz about it because it is cheap, easy, and precise. There is also a lot of mystery surrounding CRISPR, perhaps because of its more controversial uses, such as plans of resurrecting the woolly mammoth or editing human embryos, and more sci-fi uses, like eliminating malaria and other diseases from mosquitoes and growing human organs in pigs. However, right now, it’s causing its biggest revolution in the lab, where scientists are now able to manipulate and control any gene easily.
CRISPR is an acronym for Clustered Regularly Interspaced Short Palindromic Repeats. These are actually just sequences which repeat at regular intervals with spaces in-between them. Bacteria use these spaces to keep a genetic memory of viruses that have invaded it in the past. If that virus dares to show its face again, the system will recognize it and destroy it. The sequences can’t detect and destroy viruses by themselves, but they have two helpers: the enzyme Cas9 and guide RNA.
Researchers from Kanazawa University and the University of Tokyo in Japan have published a new study inNature Communications in which they visualized CRISPR-Cas9 in action, cleaving a strand of DNA in two. They visualized the process for a more detailed look at what CRISPR-Cas9 actually does. The technique that they used is called high-speed atomic-force microscopy and uses mechanical probes to get good resolution images and videos down to a nanometer. Now, you can watch the CRISPR-Cas9 complex work in real-time and real-space.
CRISPR-Cas9 is like a hand with scissors. The guide RNA is the hand that directs the scissors to bits of DNA matching info in the genetic memory, leading it to the target. When found, Cas9 are like scissors that cut the DNA and destroy it. In this video, you can see the molecular scissors at work cleaving the DNA at the end of the clip. The original sequence can be destroyed or a new sequence can be patched into the gap.
It is pretty amazing that we can see exactly what happens when CRISPR-Cas9 is at work.
Journal reference:
Shibata, M., Nishimasu, H., Kodera, N., Hirano, S., Ando, T., Uchihashi, T. & Nureki, O. (2017) Real-space and real-time dynamics of CRISPR-Cas9 visualized by high-speed atomic force microscopy. Nature Communications 8, 1430.
The good guys call themselves the Future of Life Institute. The bad guys are smart drones called Slaughterbots that can swarm a crowd yet kill precisely, delivering an explosive to the forehead of selected individuals while letting the others run in terror … or cheer the killing. While it sounds like a great plot for a dystopian movie or a sci-fi series, the Future of Life Institute is a real organization. And the Slaughterbots?
“Slaughterbots” the video (link here) was released this week by the Future of Life Institute at the United Nations Convention on Certain Conventional Weapons held in Geneva. The purpose of the Convention “is to ban or restrict the use of specific types of weapons that are considered to cause unnecessary or unjustifiable suffering to combatants or to affect civilians indiscriminately.” The mission of the Future of Life Institute is “To catalyze and support research and initiatives for safeguarding life and developing optimistic visions of the future, including positive ways for humanity to steer its own course considering new technologies and challenges.” The purpose of the video is “safeguarding life” from tiny autonomous armed drones that can kill without human initiation based on things like data collected from social media.
Uh-oh.
The Future of Life Institute created the fictional (for now) video in conjunction with the Campaign to Stop Killer Robots, an international coalition working to preemptively ban fully autonomous weapons. It sound like the Convention on Certain Conventional Weapons is the perfect place to fight for such a ban … if it’s not too late.
Stuart Russell — Professor of Computer Science and Smith-Zadeh Professor in Engineering at the University of California, Berkeley, and a leading AI researcher – closes the video with a warning about Slaughterbots:
“Its potential to benefit humanity is enormous, even in defense. But allowing machines to choose to kill humans will be devastating to our security and freedom. Thousands of my fellow researchers agree. We have an opportunity to prevent the future you just saw, but the window to act is closing fast.”
The goal of the Campaign to Stop Killer Robots is not to restrict innovation in AI and drones but to stop the use if AI for selecting and killing without having a human in the decision-making process or pulling the trigger. The AI technology shown in the video is admittedly fictional but the components are recognizable in current devices, drones and social media.
Perhaps the most disturbing part of the video is not the killing but the cheering. It’s just as easy to imagine this happening as well. Maybe that’s what the powers-that-be should focus on when deciding whether to ban slaughterbots.
The robot dog of the future is getting smarter. SpotMini, created by Boston Dynamics, has improved dramatically since its June debut. It’s designed to complete household chores while using its four legs to maintain balance, and a new video released Monday shows the incredible progress the company has made.
In the 24-second video, SpotMini runs up to the camera, peers down to look at the viewer, then lifts itself up and hops along on its way. Unlike its predecessors, which looked like a mesh of wires and metal bars, the new version has a fetching yellow exterior that makes it look more like a cute toy than some sort of military bot. If this dog-like machine is going to live alongside the rest of a family, you want it to look as friendly as possible.
The bot also appears to have a smoother motion. In previous demonstrations, the 55-pound SpotMini has been seen using a retractable arm located in its back to help out around the house, carefully moving objects to avoid dropping them. It can pick up cans, load up a dishwasher, and even do a little dance. During the 16 months since its debut, SpotMini has come on leaps and bounds to develop into a bot that wouldn’t look amiss alongside the Roomba autonomous vacuum cleaner or the Amazon Echo A.I. voice assistant.
At this stage, it’s unclear where SpotMini’s future lies. Japanese telecommunications firm SoftBank announced its purchase of Boston Dynamics back in June, taking over from Google parent company Alphabet. SoftBank is known in robotics for its Pepper customer assistant, a humanoid bot with a touchscreen on its front for taking orders in hi-tech stores.
“Smart robotics are going to be a key driver of the next stage of the information revolution, and Marc (Raibert) and his team at Boston Dynamics are the clear technology leaders in advanced dynamic robots,” SoftBank Group Chairman Masayoshi Son said at the time of the purchase.
Beste bezoeker, Heb je zelf al ooit een vreemde waarneming gedaan, laat dit dan even weten via email aan Frederick Delaere opwww.ufomeldpunt.be. Deze onderzoekers behandelen jouw melding in volledige anonimiteit en met alle respect voor jouw privacy. Ze zijn kritisch, objectief maar open minded aangelegd en zullen jou steeds een verklaring geven voor jouw waarneming! DUS AARZEL NIET, ALS JE EEN ANTWOORD OP JOUW VRAGEN WENST, CONTACTEER FREDERICK. BIJ VOORBAAT DANK...
Druk op onderstaande knop om je bestand , jouw artikel naar mij te verzenden. INDIEN HET DE MOEITE WAARD IS, PLAATS IK HET OP DE BLOG ONDER DIVERSEN MET JOUW NAAM...
Druk op onderstaande knop om een berichtje achter te laten in mijn gastenboek
Alvast bedankt voor al jouw bezoekjes en jouw reacties. Nog een prettige dag verder!!!
Over mijzelf
Ik ben Pieter, en gebruik soms ook wel de schuilnaam Peter2011.
Ik ben een man en woon in Linter (België) en mijn beroep is Ik ben op rust..
Ik ben geboren op 18/10/1950 en ben nu dus 74 jaar jong.
Mijn hobby's zijn: Ufologie en andere esoterische onderwerpen.
Op deze blog vind je onder artikels, werk van mezelf. Mijn dank gaat ook naar André, Ingrid, Oliver, Paul, Vincent, Georges Filer en MUFON voor de bijdragen voor de verschillende categorieën...
Veel leesplezier en geef je mening over deze blog.